Usher syndrome is a rare genetic condition known for causing both hearing impairment and vision loss, making it a leading cause of deaf-blindness globally. This syndrome is categorized into three main types, each varying in the severity and onset of symptoms.
Type 1 typically presents with profound congenital deafness, balance issues due to vestibular dysfunction, and early-onset retinitis pigmentosa (RP), a condition causing progressive vision loss from childhood.
Type 2 is characterized by moderate to severe hearing loss from birth and later onset RP, usually appearing in adolescence.
Type 3 shows progressive hearing loss, varying onset of RP, and different levels of vestibular dysfunction.
While there is currently no cure for Usher syndrome, early detection and intervention can help manage symptoms and improve the quality of life for affected individuals. Ongoing research into gene therapy and other treatments offers promise for future therapeutic advancements.







Title : Why a paediatric orthoptic oncology service matters
Shenika Tailor, University Hospitals of Leicester NHS Trust, United Kingdom
Title : Stereotactic radiotherapy for wet age-related macular degeneration: year 4 results of a randomised, double-masked, sham-controlled trial
Tim Jackson, King’s College London, United Kingdom